©2013 McKesson Specialty Health. All rights reserved. Accelerating cancer trials in rare tumors An innovative approach supports the future of personalized medicine Case Study: A unique research model addresses a pharmaceutical sponsor’s identification and enrollment obstacles for a cancer trial targeting patients with a rare tumor type. AT A GLANCE Need: A pharmaceutical sponsor was developing a targeted therapy for a rare carcinoma tumor and anticipated enrollment challenges. Using the traditional industry method meant that the sponsor would have to preselect and open numerous sites to screen and identify 10 patients who would meet the study criteria. The sponsor needed a different approach that would allow the efficient identification of the required patient population within

Join for free to read